Signaling Pathways Used by the Specialized Pro-Resolving Mediator Maresin 2 Regulate Goblet Cell Function: Comparison with Maresin 1

被引:5
|
作者
Olsen, Markus, V [1 ,2 ,3 ]
Lyngstadaas, Anne, V [1 ,2 ,3 ]
Bair, Jeffrey A. [1 ]
Hodges, Robin R. [1 ]
Utheim, Tor P. [1 ,4 ]
Serhan, Charles N. [5 ,6 ]
Dartt, Darlene A. [1 ,7 ]
机构
[1] Harvard Med Sch, Schepens Eye Res Inst Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02114 USA
[2] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway
[3] Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway
[4] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, N-0424 Oslo, Norway
[5] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesia, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA 02115 USA
[7] Univ Oslo, Fac Dent, Dept Oral Biol, N-0316 Oslo, Norway
基金
美国国家卫生研究院;
关键词
mucin secretion; intracellular Ca2+; inflammation; epithelial cell; tear film; eye; INCREASE INTRACELLULAR CA2+; PROTEIN-COUPLED RECEPTOR; OCULAR SURFACE; MUCIN SECRETION; LEUKOTRIENE B-4; INFLAMMATION; HISTAMINE; MUC5AC; E1; D1;
D O I
10.3390/ijms23116233
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Specialized pro-resolving mediators (SPMs), including Maresins (MaR)-1 and 2, contribute to tear film homeostasis and resolve conjunctival inflammation. We investigated MaR2 ' s signaling pathways in goblet cells (GC) from rat conjunctiva. Agonist-induced [Ca2+](i) and high-molecular weight glycoconjugate secretion were measured. MaR2 increased [Ca2+](i) and stimulated secretion. MaR2 and MaR1 stimulate conjunctival goblet cell function, especially secretion, by activating different but overlapping GPCR and signaling pathways, and furthermore counter-regulate histamine stimulated increase in [Ca2+](i). Thus, MaR2 and MaR1 play a role in maintaining the ocular surface and tear film homeostasis in health and disease. As MaR2 and MaR1 modulate conjunctival goblet cell function, they each may have potential as novel, but differing, options for the treatment of ocular surface inflammatory diseases including allergic conjunctivitis and dry eye disease. We conclude that in conjunctival GC MaR2 and MaR1, both increase the [Ca2+](i) and stimulate secretion to maintain homeostasis by using one set of different, but overlapping, signaling pathways to increase [Ca2+](i) and another set to stimulate secretion. MaR2 also resolves ocular allergy.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] 15-Deoxy-Δ12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling
    Surh, Young-Joon
    Na, Hye-Kyung
    Park, Jong-Min
    Lee, Ha-Na
    Kim, Wonki
    Yoon, In-Soo
    Kim, Dae-Duk
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1335 - 1351
  • [32] Anti-Inflammatory and Pro-resolving Actions of the N-Terminal Peptides Ac2-26, Ac2-12 and Ac9-25 of Annexin A1 on Conjunctival Goblet Cell Function
    Dartt, Darlene
    Lyngstadaas, Anne
    Olsen, Markus
    Bair, Jeffrey
    Utheim, Tor
    Serhan, Charles
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [33] Anti-Inflammatory and Pro-Resolving Actions of the N-Terminal Peptides Ac2-26, Ac2-12, and Ac9-25 of Annexin A1 on Conjunctival Goblet Cell Function
    Lyngstadaas, Anne, V
    Olsen, Markus, V
    Bair, Jeffrey
    Yang, Menglu
    Hodges, Robin R.
    Utheim, Tor P.
    Serhan, Charles N.
    Dartt, Darlene A.
    AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (11): : 1817 - 1832
  • [34] ALTERATIONS IN LIVER REGENERATION CAUSED BY ETHANOL AND GALACTOSAMINE CHALLENGE WERE IMPROVED BY THE N-3 PUFA-DERIVED SPECIALIZED PRO-RESOLVING MEDIATOR, RESOLVIN D1
    Hardesty, J. E.
    Warner, J. B.
    Warner, D. R.
    McClain, C. J.
    Kirpich, I. A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 141A - 141A
  • [35] ADULT-ONSET STILL′S DISEASE AND COVID 19 SHARE GENETIC EXPRESSION RELATED TO HYPERINFLAMMATION: DEFINING THE POSSIBLE ROLE OF THE SPECIALIZED PRO-RESOLVING LIPID MEDIATOR PROTECTIN D1 IN MODULATING MACROPHAGES POLARIZATION AND FUNCTION
    Navarini, L.
    Vomero, M.
    Currado, D.
    Berardicurti, O.
    Biaggi, A.
    Marino, A.
    Bearzi, P.
    Corberi, E.
    Rigon, A.
    Arcarese, L.
    Leuti, A.
    Fava, M.
    Fogolari, M.
    Mattei, A.
    Ruscitti, P.
    Di Cola, I.
    Sambuco, F.
    Travaglino, F.
    Angeletti, S.
    Ursini, F.
    Mariani, E.
    Agro, F. E.
    Cipriani, P.
    Iagnocco, A.
    Incalzi, R. Antonelli
    Maccarrone, M.
    Giacomelli, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 351 - 352
  • [36] Maresin1 ameliorates sepsis-associated lung injury by inhibiting the activation of the JAK2/STAT3 and MAPK/NF-κB signaling pathways
    Wang, Fuquan
    Wang, Min
    Wang, Jingxu
    Chen, Ming
    Sun, Shujun
    Yao, Shanglong
    Xia, Haifa
    MICROBIAL PATHOGENESIS, 2020, 148
  • [37] The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection
    Gallo, Claudio G.
    Fiorino, Sirio
    Posabella, Giovanni
    Antonacci, Donato
    Tropeano, Antonio
    Pausini, Emanuele
    Pausini, Carlotta
    Guarniero, Tommaso
    Hong, Wandong
    Giampieri, Enrico
    Corazza, Ivan
    Loiacono, Rossella
    Loggi, Elisabetta
    de Biase, Dario
    Zippi, Maddalena
    Lari, Federico
    Zancanaro, Marco
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2022, 159
  • [38] Specialized pro-resolving mediator 7S MaR1 inhibits IL-6 expression via modulating ROS/p38/ERK/NF-κB pathways in PM10-exposed keratinocytes
    Kim, Jinju
    Park, Hyo-Min
    Lim, Chae-Min
    Jeon, Kyeong-Bae
    Kim, Seonhwa
    Lee, Jin
    Hong, Jin-Tae
    Oh, Deok-Kun
    Yang, Young
    Yoon, Do-Young
    BMB REPORTS, 2024, 57 (11) : 490 - 496
  • [39] Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study
    Kübra Karakoç Güvenç
    Özlem Fentoğlu
    Mustafa Calapoğlu
    Fatih Aksoy
    Hikmet Orhan
    Clinical Oral Investigations, 2023, 27 : 5549 - 5558
  • [40] Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study
    Guvenc, Kuebra Karakoc
    Fentoglu, Ozlem
    Calapoglu, Mustafa
    Aksoy, Fatih
    Orhan, Hikmet
    CLINICAL ORAL INVESTIGATIONS, 2023, 27 (09) : 5549 - 5558